$GOOD

Gladstone Commercial Corporation (GOOD) Sets Oct–Dec 2026 Dividends, Q3 Dates

Gladstone Commercial (GOOD) declared quarterly dividends of $0.10 per common share and $0.0875 per senior common share for Oct–Dec 2026. The company will report Q3 2026 earnings on Nov 3 and host a call on Nov 4. According to the company, this continues its streak of monthly distributions.

Original reporting
Published Oct 13, 2026, 8:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 8:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Gladstone Commercial Corporation (GOOD) Sets Oct–Dec 2026 Dividends, Q3 Dates — source image
Decision brief

The 30-second read

$GOODNeutralLow
01

Why it matters

The new dividend rates provide a small positive catalyst for the stock, primarily for income‑oriented investors.

02

Market read

A routine dividend update with limited price impact but relevance for dividend‑seeking traders.

03

What to watch

Potential changes in FFO guidance later this quarter could outweigh the dividend news.

Relevance 5/10Novelty 5/10Timing: effective immediately

Background

Gladstone Commercial regularly issues monthly dividends; this announcement confirms continuation of its payout policy.

Company-level read

Ticker impact

$GOODNeutralHigh confidence
Context

Gladstone Commercial announced its October‑December 2026 dividend amounts of $0.10 per common share and $0.0875 per senior common share.

Expected impact

likely modest upside as income investors price in the stable payout

Evidence & confidence

The announcement is a primary corporate action with new dividend figures; no other material news accompanies it.

Market effects

May reinforce the appeal of REITs in the commercial real‑estate sector.

Limited to U.S. REIT investors.

Minimal global impact.

Counterpoint

The modest dividend increase may be insufficient if earnings pressure rises, prompting a sell‑off.

Key entities

  • Gladstone Commercial Corporation

    U.S. REIT focused on commercial real estate.

Related articles

$GOODMed

Gladstone Commercial Corporation Reports Results for the Second Quarter Ended June 30, 2026

GLADSTONE COMMERCIAL CORP (GOOD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Gladstone Commercial Corporation Reports Results for the Second Quarter Ended June 30, 2026 Please note that the limited information that follows in this press release is not adequate to make an informed investment judgment. MCLEAN, VA, August 5, 2026 (ACCESSWIRE) -- Gladstone Co

$GOODHighAI 9/10

F&P Healthcare weighs on NZX50 ahead of earnings

New Zealand’s S&P/NZX 50 fell 0.2% to 12,970.28 as exporters and property stocks were broadly weaker ahead of Fisher & Paykel Healthcare’s annual earnings on Tuesday and Goodman New Zealand’s results. F&P shares slipped 1.3% to $33.66. Oceania Healthcare rose 2.8% after brokers lifted targets. Outside the index, Pacific Edge gained 3.7% while Eroad fell 8% after missing guidance; Ampfield seeks board control.

$RIOMed

Rio Tinto eyes $A7b capital release, iron ore sales up

Rio Tinto reported a 2% increase in Pilbara iron ore sales to 85.7 million tonnes, exceeding estimates. The company aims to release $7.2 billion in capital by 2026, with $2 billion already released this year. Copper output remained flat, and lithium production is expected at the lower end of forecasts. Iron ore sales for 2026 are forecasted between 323-338 million tonnes.

$SNYMed

Korea health agency lets Sanofi cut NIP flu supply, igniting favoritism furor

Sanofi-Aventis Korea reduced its National Immunization Program (NIP) flu vaccine supply from 2.25M to 1.75M doses due to production disruptions. The Korea Disease Control and Prevention Agency amended the contract without penalties, allowing Sanofi to divert 500,000 doses to the higher-priced private market. Critics argue this favors Sanofi and may disrupt supply for domestic firms like GCGC Biopharma (006280).

$GETYHighAI 8/10

Getty Images files for Bankruptcy

Getty Images (OTCPK: GETY) filed for Chapter 11 bankruptcy, delisting from the NYSE. The company secured a restructuring deal with Koch Equity Development and the Getty family, wiping out debt and going private. The move follows a failed merger with Shutterstock and declining subscriber numbers due to AI competition. Operations will continue as usual.

MedAI 8/10

Getty Images to keep Seattle HQ as it goes private through bankruptcy

Getty Images plans to keep its Seattle HQ and avoid layoffs as it goes private through bankruptcy to cut debt. The company reported $981M revenue and $84M operating income in 2023, but a $206M net loss. Getty's debt totals $1.5B, with a failed merger and AI competition impacting its business. Koch Equity Development will invest $533M. Trading was suspended after shares fell to 12 cents.